Leonteq Securities AG’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Leonteq Securities AG's TXG Position: Q2 2026 in Review
Leonteq Securities AG reduced its 10x Genomics (TXG) stake by 57% in Q2 2026, selling an estimated $1.07K and leaving 31 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1173.
Leonteq Securities AG first reported a position in TXG in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.73M in Q2 2025. 389 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Leonteq Securities AG held 31 shares of 10x Genomics worth $1.19K as of Q2 2026.
- Leonteq Securities AG sold 41 10x Genomics shares in Q2 2026, an estimated $1.07K.
- 10x Genomics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1173 holding.
- Leonteq Securities AG first reported a position in 10x Genomics in Q1 2021 and has held it in 19 quarters since.
- Leonteq Securities AG's 10x Genomics position peaked at $1.73M in Q2 2025.
- 389 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.